Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence from a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization Jie Zheng , Eleanor Wheeler , Maik Pietzner , Till F. M. Andlauer , Michelle S. Yau , April E. Hartley , Ben Michael Brumpton , Humaira Rasheed , John P. Kemp , Monika Frysz , Jamie Robinson , Sjur Reppe , Vid Prijatelj , Kaare M. Gautvik , Louise Falk , Winfried Maerz , Ingrid Gergei , Patricia A. Peyser , Maryam Kavousi , Paul S. de Vries , Clint L. Miller , Maxime Bos , Sander W. van Der Laan , Rajeev Malhotra , Markus Herrmann , Hubert Scharnagl , Marcus Kleber , George Dedoussis , Eleftheria Zeggini , Maria Nethander , Claes Ohlsson , Mattias Lorentzon , Nick Wareham , Claudia Langenberg , Michael V. Holmes , George Davey Smith , Jonathan H. Tobias ARTHRITIS & RHEUMATOLOGY（2023）
Key words
Atherosclerotic Cardiovascular Risk, Sclerostin, Cholesterol-lowering
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
